NIH-funded research R01 grant

How pregnancy changes gene activity in rheumatoid arthritis

Official title: The Pregnancy Transcriptome in Rheumatoid Arthritis - Renewal

Funded at Northwestern University · NIH-11133211 · Data updated 2026-11-12

This project looks at gene activity in women with rheumatoid arthritis during pregnancy to find signals that predict who will improve or worsen.

More Pregnancy research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionNorthwestern University
NIH-funded
Lab location1 site (Chicago, United States)
Project startSeptember 20, 2017
Project endAugust 31, 2030
Funding year2025
Award (this year)$676,608
NIH project number2R01AR073111-06A1
Project IDNIH-11133211 on NIH RePORTER

Who could benefit from this research

Could help

Women with rheumatoid arthritis who are planning pregnancy or are in early pregnancy would be the ideal candidates for participation.

Less likely to help

People without rheumatoid arthritis, men, or women not planning pregnancy are unlikely to benefit directly from this work.

What this research studies

If you are a woman with rheumatoid arthritis planning pregnancy or already pregnant, researchers will collect blood samples before and during pregnancy to measure gene activity and other molecular markers. They will compare people who naturally get better in pregnancy with those who do not to find patterns that predict outcomes. The team uses advanced 'omics' tools to read immune cell activity and identify biomarkers and potential targets for new treatments. Findings aim to help doctors tailor care during pregnancy and inspire therapies that mimic pregnancy's protective effects without its risks.

Why it matters

Potential benefit: Could enable prediction of who will improve or worsen during pregnancy and point to new treatments that reproduce pregnancy's helpful effects without pregnancy-related risks.

How similar studies have gone: Clinicians have long observed pregnancy-linked improvement in RA, but applying pregnancy transcriptomics to predict outcomes and find drug targets is relatively new with limited prior successes.

Where this research is happening

  • Northwestern University
    Chicago, United States
    Active

Researchers

  • Principal investigator: Jawaheer, Damini — Northwestern University
  • Study coordinator: Jawaheer, Damini

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.